Product
Target
Indication
Commercial Rights
Discovery
IND-Enabling
Phase l
Phase ll
Phase lll
-
SR128
Undisclosed
AD *
Global
Discovery
IND-Enabling
Phase l
Phase ll
Phase lll
-
SR131
Undisclosed
Pain
Global
Discovery
IND-Enabling
Phase l
Phase ll
Phase lll
-
SR144
Undisclosed
ALS *
Global
Discovery
IND-Enabling
Phase l
Phase ll
Phase lll
* AD: Alzheimer's Disease; ALS: Amyotrophic Lateral Sclerosis.